Cargando…

CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence

BACKGROUND: Multiple early gastric cancers (EGCs) may develop in 6–14% of patients even after achieving curative endoscopic submucosal dissection (ESD); however, a useful biomarker for predicting recurrence is not available. The present study investigated whether the expression of CD44 variant 9 (CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirata, K, Suzuki, H, Imaeda, H, Matsuzaki, J, Tsugawa, H, Nagano, O, Asakura, K, Saya, H, Hibi, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721391/ https://www.ncbi.nlm.nih.gov/pubmed/23778530 http://dx.doi.org/10.1038/bjc.2013.314

Ejemplares similares

CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma
por: Okabe, H, et al.
Publicado: (2014)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis
por: Zheng, H-C, et al.
Publicado: (2006)

Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer
por: Kodama, Hirokazu, et al.
Publicado: (2017)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay
por: Osako, T, et al.
Publicado: (2013)

NY-ESO-1 antibody as a novel tumour marker of gastric cancer
por: Fujiwara, S, et al.
Publicado: (2013)

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia
por: Nankivell, P, et al.
Publicado: (2013)

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers
por: Lee, Y-K, et al.
Publicado: (2009)

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
por: Hao, J, et al.
Publicado: (2010)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation
por: Sugimachi, K, et al.
Publicado: (2015)

C4.4A as a candidate marker in the diagnosis of colorectal cancer
por: Paret, C, et al.
Publicado: (2007)

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers
por: Miyamoto, M, et al.
Publicado: (2015)

OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome
por: Staibano, S, et al.
Publicado: (2007)

Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis
por: Griffiths, E A, et al.
Publicado: (2008)

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer
por: Sakakibara, T, et al.
Publicado: (2005)

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)

Tumour-associated CD66b(+) neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer
por: Carus, A, et al.
Publicado: (2013)

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma
por: Tanaka, N, et al.
Publicado: (2008)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells
por: Miki, Yuichiro, et al.
Publicado: (2018)

Sequential expression of putative stem cell markers in gastric carcinogenesis
por: Wang, T, et al.
Publicado: (2011)

Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer
por: Hasuo, T, et al.
Publicado: (2007)

Circulating microRNAs in plasma of patients with gastric cancers
por: Tsujiura, M, et al.
Publicado: (2010)

PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression
por: Uchi, R, et al.
Publicado: (2013)

Localisation pattern of Foxp3(+) regulatory T cells is associated with clinical behaviour in gastric cancer
por: Mizukami, Y, et al.
Publicado: (2008)

Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma
por: Kobayashi, M, et al.
Publicado: (2012)

Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer
por: Nedergaard, B S, et al.
Publicado: (2007)

Bone marrow-derived stromal cells are associated with gastric cancer progression
por: Kasashima, H, et al.
Publicado: (2015)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
por: Nishimura, Y, et al.
Publicado: (2013)

Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori–Infected CAPZA1-Overexpressing Cells
por: Tsugawa, Hitoshi, et al.
Publicado: (2019)

The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
por: Ragnum, H B, et al.
Publicado: (2015)

Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue
por: Kauppila, J H, et al.
Publicado: (2013)

FGFR2 gene amplification and clinicopathological features in gastric cancer
por: Matsumoto, K, et al.
Publicado: (2012)

Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression
por: Tsuru, A, et al.
Publicado: (2015)

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
por: Nomoto, S, et al.
Publicado: (2007)

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
por: Komatsu, S, et al.
Publicado: (2015)

miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
por: Higashi, T, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ts0u9s9fkr14vmnmr5cod6r2ga